Frequency and Effects of Excess Dosing of Anticoagulants in Patients ≤55 Years With Acute Myocardial Infarction Who Underwent Percutaneous Coronary Intervention (from the VIRGO Study)

      Excess dosing of anticoagulant agents has been linked to increased risk of bleeding after percutaneous coronary intervention (PCI) for women compared with men, but these studies have largely included older patients. We sought to determine the prevalence and gender-based differences of excess dosing of anticoagulants including glycoprotein IIb/IIIa inhibitors, bivalirudin, and unfractionated heparin in young patients with acute myocardial infarction who underwent PCI and to examine its association with bleeding. Of 2,076 patients enrolled in the Variation in Recovery: Role of Gender on Outcomes of Young Acute Myocardial Infarction Patients study who underwent PCI, we abstracted doses of unfractionated heparin, bivalirudin, and glycoprotein IIb/IIIa inhibitors administered during PCI from the medical records. At least 47.2% received at least 1 excess dose of an anticoagulant, which did not differ by gender. We used logistic regression to determine the predictors of excess dosing and the association of excess dosing with bleeding. In multivariable analysis, only lower body weight and younger age were significant predictors of excess dosing. Bleeding was higher in young women who received excess dosing versus those who did not (9.3% vs 6.0%, p = 0.03) but was comparable among men (5.2% vs 5.9%, p = 0.69) in univariate analysis. In multivariable analysis, there was a trend to an association between excess dosing and bleeding (odds ratio 1.33, 95% confidence interval 0.92 to 1.91) although not statistically significant. In conclusion, approximately half of the patients received excess dosing of anticoagulant drugs during PCI, which did not vary based on gender. There was a trend toward an association between excess dosing and increased bleeding, although not statistically significant.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to American Journal of Cardiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Kanjanarat P.
        • Winterstein A.G.
        • Johns T.E.
        • Hatton R.C.
        • Gonzalez-Rothi R.
        • Segal R.
        Nature of preventable adverse drug events in hospitals: a literature review.
        Am J Health Syst Pharm. 2003; 60: 1750-1759
        • Howard R.L.
        • Avery A.J.
        • Slavenburg S.
        • Royal S.
        • Pipe G.
        • Lucassen P.
        • Pirmohamed M.
        Which drugs cause preventable admissions to hospital? A systematic review.
        Br J Clin Pharmacol. 2007; 63: 136-147
        • Budnitz D.S.
        • Lovegrove M.C.
        • Shehab N.
        • Richards C.L.
        Emergency hospitalizations for adverse drug events in older Americans.
        N Engl J Med. 2011; 365: 2002-2012
        • Alexander K.P.
        • Chen A.Y.
        • Roe M.T.
        • Newby L.K.
        • Gibson C.M.
        • Allen-LaPointe N.M.
        • Pollack C.
        • Gibler W.B.
        • Ohman E.M.
        • Peterson E.D.
        Excess dosing of antiplatelet and antithrombin agents in the treatment of non-ST-segment elevation acute coronary syndromes.
        JAMA. 2005; 294: 3108-3116
        • Wang T.Y.
        • Chen A.Y.
        • Alexander K.P.
        • Ohman E.M.
        • Gibler W.B.
        • Peterson E.D.
        • Roe M.T.
        Excess heparin dosing among fibrinolytic-treated patients with ST-segment elevation myocardial infarction.
        Am J Med. 2008; 121: 805-810
        • Argulian E.
        • Patel A.D.
        • Abramson J.L.
        • Kulkarni A.
        • Champney K.
        • Palmer S.
        • Weintraub W.
        • Wenger N.K.
        • Vaccarino V.
        Gender differences in short-term cardiovascular outcomes after percutaneous coronary interventions.
        Am J Cardiol. 2006; 98: 48-53
        • Srinivas V.S.
        • Garg S.
        • Negassa A.
        • Bang J.Y.
        • Monrad E.S.
        Persistent sex difference in hospital outcome following percutaneous coronary intervention: results from the New York State reporting system.
        J Invasive Cardiol. 2007; 19: 265-268
        • Abramson J.L.
        • Veledar E.
        • Weintraub W.S.
        • Vaccarino V.
        Association between gender and in-hospital mortality after percutaneous coronary intervention according to age.
        Am J Cardiol. 2003; 91 (A964): 968-971
        • Radovanovic D.
        • Erne P.
        • Urban P.
        • Bertel O.
        • Rickli H.
        • Gaspoz J.M.
        Gender differences in management and outcomes in patients with acute coronary syndromes: results on 20,290 patients from the AMIS Plus Registry.
        Heart. 2007; 93: 1369-1375
        • Lichtman J.H.
        • Lorenze N.P.
        • D'Onofrio G.
        • Spertus J.A.
        • Lindau S.T.
        • Morgan T.M.
        • Herrin J.
        • Bueno H.
        • Mattera J.A.
        • Ridker P.M.
        • Krumholz H.M.
        Variation in recovery: role of gender on outcomes of young AMI patients (VIRGO) study design.
        Circ Cardiovasc Qual Outcomes. 2010; 3: 684-693
        • Kushner F.G.
        • Hand M.
        • Smith Jr., S.C.
        • King III, S.B.
        • Anderson J.L.
        • Antman E.M.
        • Bailey S.R.
        • Bates E.R.
        • Blankenship J.C.
        • Casey Jr., D.E.
        • Green L.A.
        • Hochman J.S.
        • Jacobs A.K.
        • Krumholz H.M.
        • Morrison D.A.
        • Ornato J.P.
        • Pearle D.L.
        • Peterson E.D.
        • Sloan M.A.
        • Whitlow P.L.
        • Williams D.O.
        2009 focused updates: ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction (updating the 2004 guideline and 2007 focused update) and ACC/AHA/SCAI guidelines on percutaneous coronary intervention (updating the 2005 guideline and 2007 focused update) a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.
        J Am Coll Cardiol. 2009; 54: 2205-2241
        • Michels W.M.
        • Grootendorst D.C.
        • Verduijn M.
        • Elliott E.G.
        • Dekker F.W.
        • Krediet R.T.
        Performance of the Cockcroft-Gault, MDRD, and new CKD-EPI formulas in relation to GFR, age, and body size.
        Clin J Am Soc Nephrol. 2010; 5: 1003-1009
        • Reichlin T.
        • Hochholzer W.
        • Bassetti S.
        • Steuer S.
        • Stelzig C.
        • Hartwiger S.
        • Biedert S.
        • Schaub N.
        • Buerge C.
        • Potocki M.
        • Noveanu M.
        • Breidthardt T.
        • Twerenbold R.
        • Winkler K.
        • Bingisser R.
        • Mueller C.
        Early diagnosis of myocardial infarction with sensitive cardiac troponin assays.
        N Engl J Med. 2009; 361: 858-867
        • Mehta S.K.
        • Frutkin A.D.
        • Lindsey J.B.
        • House J.A.
        • Spertus J.A.
        • Rao S.V.
        • Ou F.S.
        • Roe M.T.
        • Peterson E.D.
        • Marso S.P.
        Bleeding in patients undergoing percutaneous coronary intervention: the development of a clinical risk algorithm from the National Cardiovascular Data Registry.
        Circ Cardiovasc Interv. 2009; 2: 222-229
      1. Healthcare Cost and Utilization Project. HCUP methods series. Available at: Accessed on December 26, 2013.

        • Alexander K.P.
        • Chen A.Y.
        • Newby L.K.
        • Schwartz J.B.
        • Redberg R.F.
        • Hochman J.S.
        • Roe M.T.
        • Gibler W.B.
        • Ohman E.M.
        • Peterson E.D.
        Sex differences in major bleeding with glycoprotein IIb/IIIa inhibitors: results from the CRUSADE (Can Rapid risk stratification of Unstable angina patients Suppress Adverse outcomes with Early implementation of the ACC/AHA guidelines) initiative.
        Circulation. 2006; 114: 1380-1387